Literature DB >> 18709343

Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

Anne Eckert1, Susanne Hauptmann, Isabel Scherping, Jessica Meinhardt, Virginie Rhein, Stefan Dröse, Ulrich Brandt, Marcus Fändrich, Walter E Müller, Jürgen Götz.   

Abstract

We recently provided evidence for a mitochondrial dysfunction in P301L tau transgenic mice, a strain modeling the tau pathology of Alzheimer's disease (AD) and frontotemporal dementia (FTD). In addition to tau aggregates, the AD brain is further characterized by A beta peptide-containing plaques. When we addressed the role of A beta, this indicated a synergistic action of tau and A beta pathology on the mitochondria. In the present study, we compared the toxicity of different A beta 42 conformations in light of recent studies suggesting that oligomeric rather than fibrillar A beta might be the actual toxic species. Interestingly, both oligomeric and fibrillar, but not disaggregated (mainly monomeric) A beta 42 caused a decreased mitochondrial membrane potential in cortical brain cells obtained from FTD P301L tau transgenic mice. This was not observed with cerebellar preparations indicating selective vulnerability of cortical neurons. Furthermore, we found reductions in state 3 respiration, the respiratory control ratio, and uncoupled respiration when incubating P301L tau mitochondria either with oligomeric or fibrillar preparations of A beta 42. Finally, we found that aging specifically increased the sensitivity of mitochondria to oligomeric A beta 42 damage indicating that oligomeric and fibrillar A beta 42 are both toxic, but exert different degrees of toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709343     DOI: 10.1007/s00109-008-0391-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  55 in total

1.  Mitochondrial respiratory chain activity in the human brain as a function of age.

Authors:  J Ojaimi; C L Masters; K Opeskin; P McKelvie; E Byrne
Journal:  Mech Ageing Dev       Date:  1999-11-02       Impact factor: 5.432

2.  FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

Authors:  Giorgia Zandomeneghi; Mark R H Krebs; Margaret G McCammon; Marcus Fändrich
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

3.  The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation.

Authors:  Peter Hortschansky; Volker Schroeckh; Tony Christopeit; Giorgia Zandomeneghi; Marcus Fändrich
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

Review 4.  Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis.

Authors:  Charles G Glabe; Rakez Kayed
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 5.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

6.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

Authors:  Stefan Barghorn; Volker Nimmrich; Andreas Striebinger; Carsten Krantz; Patrick Keller; Bodo Janson; Michael Bahr; Martin Schmidt; Robert S Bitner; John Harlan; Eve Barlow; Ulrich Ebert; Heinz Hillen
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

Review 7.  The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

Authors:  D M Walsh; I Klyubin; G M Shankar; M Townsend; J V Fadeeva; V Betts; M B Podlisny; J P Cleary; K H Ashe; M J Rowan; D J Selkoe
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

Review 8.  Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.

Authors:  Frederic Hoerndli; Della C David; Jürgen Götz
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

Review 9.  Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.

Authors:  Javier Díaz-Nido; Francisco Wandosell; Jesús Avila
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

10.  Mitochondrial function in brain tissue in primary degenerative dementia.

Authors:  N R Sims; J M Finegan; J P Blass; D M Bowen; D Neary
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

View more
  55 in total

1.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

2.  Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.

Authors:  Nyosha Alikhani; Lan Guo; Shiqiang Yan; Heng Du; Catarina Moreira Pinho; John Xi Chen; Elzbieta Glaser; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Aβ oligomer-induced synapse degeneration in Alzheimer's disease.

Authors:  Kyle C Wilcox; Pascale N Lacor; Jason Pitt; William L Klein
Journal:  Cell Mol Neurobiol       Date:  2011-05-03       Impact factor: 5.046

Review 4.  Recent progress in understanding Alzheimer's β-amyloid structures.

Authors:  Marcus Fändrich; Matthias Schmidt; Nikolaus Grigorieff
Journal:  Trends Biochem Sci       Date:  2011-03-14       Impact factor: 13.807

Review 5.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

6.  Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Authors:  Nicole Schonrock; Yazi D Ke; David Humphreys; Matthias Staufenbiel; Lars M Ittner; Thomas Preiss; Jürgen Götz
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 7.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

8.  An update on the toxicity of Abeta in Alzheimer's disease.

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock; Roberto Cappai
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

9.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

Review 10.  Alzheimer's disease: insights from Drosophila melanogaster models.

Authors:  Aileen Moloney; David B Sattelle; David A Lomas; Damian C Crowther
Journal:  Trends Biochem Sci       Date:  2009-12-25       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.